Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration Pharmaceutical Investing
Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States Pharmaceutical Investing
Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference Pharmaceutical Investing
Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch Pharmaceutical Investing
Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design Pharmaceutical Investing
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study Pharmaceutical Investing
Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial Pharmaceutical Investing
